News and Press Releases

The conclusion of this series examines the benefits, and drawbacks, of probiotics. Stanford researchers clarify whether probiotics really improve health.

Immunotherapy has great promise as a cancer treatment, but current therapies only work in some. Now, Stanford researchers are testing the idea that microorganisms in our guts might be the deciding factor.

Scientists have used CRISPR-Cas9 gene editing technology to decipher the genes critical to the success of a type of cancer drug, antibody-drug conjugates.

In the third in a series on what the lives of Stanford researchers actually look like, chemists Noah Burns, Laura Dassama, Michael Fayer and Hemamala Karunadasa talk about their paths into the field, the joys of making new molecules and the way in which “the central science” pervades our lives.

Stanford engineers have developed experimental stickers that pick up physiological signals emanating from the skin, then wirelessly beam these health readings to a receiver clipped onto clothing. It’s all part of a system called BodyNet.

The Stanford Microbiome Therapies Initiative is backed by gifts from Marc and Lynne Benioff and Mark and Debra Leslie and is focused on developing and testing new disease therapies

The bacteria in our gut make thousands of tiny, previously unidentified proteins that could shed light on human health and advance drug development, Stanford researchers have found.

Applying a gel to internal tissues of animals after cardiac surgery significantly limits the formation of adhesions, a problematic form of scar tissue, Stanford researchers have found.

Stanford researchers have identified immune cells that help reduce the severity of a disease in mice akin to multiple sclerosis. These cells could one day be useful therapeutic targets in treating autoimmune diseases.